Lower risk Drug recall · FDA · Published April 10, 2025

Eugia Testosterone Cypionate Injection Recall: Crystals May Not Redissolve After Warming

Eugia recalls 200mg testosterone vials due to crystals not redissolving after warming. This affects patients using the injection for medical treatment. Contact Eugia for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0363-2025Drug Eugia ›

Lower-risk recall

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Take action

Contact the company

Recalling firmEugia US LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401

✎ GovInfoNow plain-language explainer

Eugia is recalling testosterone injections that may have crystals not dissolving after warming. This could affect medical treatment if the injection isn't properly prepared. Read more at govinfonow.com/recall/32151-eugia-testosterone-cypionate-injection-recall-crystals-may-not-redissolve-after.

Source Summary by GovInfoNow · govinfonow.com/recall/32151-eugia-testosterone-cypionate-injection-recall-crystals-may-not-redissolve-after · Updated August 17, 2026 · FDA enforcement record: FDA #D-0363-2025

Cite this page

“Eugia Testosterone Cypionate Injection Recall: Crystals May Not Redissolve After Warming.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32151-eugia-testosterone-cypionate-injection-recall-crystals-may-not-redissolve-after. Based on FDA recall #D-0363-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0363-2025%22&limit=1).

Eugia US LLC voluntarily recalled Testosterone Cypionate Injection, USP, CIII distributed nationwide on April 10, 2025, according to the FDA. The recall addresses complaints of crystals not redissolving into solution after warming and shaking the vials.

How to tell if you have it

Brand: Eugia
Product: Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial
NDC: 55150-277-01
Lot #: 1TC24075A
Expiration: 11/30/2026
Quantity: 36,816 vials

The hazard

The FDA stated the hazard involves current Good Manufacturing Practice (cGMP) issues, specifically complaints of crystals not redissolving into solution after warming and shaking the vials.

Context

GovInfoNow's records show Eugia US LLC has issued 14 other recalls since December 28, 2022. Recent Eugia recalls include a May 29, 2025 Gentamicin Injection recall due to stability failure and an April 21, 2025 Tirofiban injection recall for out-of-specification related substances. Other recent recalls of similar products include Endo USA Buprenorphine Injection Recall (March 13, 2026) and FarmaKeio Testosterone Pellets Recall (October 14, 2025).

How to tell if you have this one

Check for the vial labeled 'Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial' with NDC 55150-277-01 and lot number 1TC24075A.

Brand
Eugia
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Vial Label
Look for the NDC code 55150-277-01 and lot number 1TC24075A on the vial.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

Apr 10, 2025Firm started the recall
Apr 14, 2025FDA classified it Class II
Apr 23, 2025Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/32151-eugia-testosterone-cypionate-injection-recall-crystals-may-not-redissolve-after">Eugia Testosterone Cypionate Injection Recall: Crystals May Not Redissolve After Warming (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0363-2025 (April 10, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0363-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.